289913-98-0

Upstream product

• 123-75-1 pyrrolidine 
• 1635-61-6 5-chloro-2-nitroaniline 

Downstream Products

• 1234802-61-9 N-(5-(pyrrolidin-1-yl)-2-(3,4,5-trimethoxybenzylamino)phenyl)benzamide 
• 1234802-60-8 (E)-N-(5-(pyrrolidin-1-yl)-2-(3,4,5-trimethoxybenzylideneamino)phenyl)benzamide 
• 1234802-62-0 N-(2-amino-5-(pyrrolidin-1-yl)phenyl)benzamide 
• 1234802-01-7 2-phenyl-5-(pyrrolidin-1-yl)-1-(3,4,5-trimethoxybenzyl)-1H-benzo[d]imidazole 
• 1234802-59-5 N-(2-nitro-5-(pyrrolidin-1-yl)phenyl)benzamide 

Relevant academic research and scientific papers

Pyrazole spleen tyrosine kinase inhibitor as well as preparation method and application thereof

The invention discloses a pyrazole spleen tyrosine kinase inhibitor, a preparation method thereof, a pharmaceutical composition containing the same, and application of the pyrazole spleen tyrosine kinase inhibitor and the pharmaceutical composition in the preparation of drugs for treating Syk-mediated diseases including cancers, inflammatory diseases and the like.

Dihydrobenzo imidazolecarboxylic compd. and its use

PROBLEM TO BE SOLVED: To provide a benzimidazole compound for use as an antiplatelet agent or an antithrombotic agent, or for use in the treatment of cancer or cardiovascular and cerebrovascular diseases, and to provide a pharmaceutical composition con

Benzimidazole compounds and their use

Benzimidazole compounds of formula (I): wherein R1, R2, R3, R4, R5, X, Y, Z1, and Z2 are defined herein. Also disclosed is a pharmaceutical composition comprising the benzimidazo

BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS ANTICANCER AGENTS

Benzimidazole compounds of formula (I): wherein R1, R2, R3, R4, R5, X, Y, Z1, and Z2 are defined herein. Also disclosed is a method for treating cancer with benzimidazole compoun